Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET
Authors:
Open Access
- 5 November 2008
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (3) , 382-388
Abstract
We prospectively investigated the feasibility of 3′-deoxy-3′-18F-fluorothymidine (FLT) positron emission tomography (PET) for the detection of gastric cancer, in comparison with 2-deoxy-2-18F-fluoro-d-glucose (FDG) PET, and determined the degree of correlation between the two radiotracers and proliferative activity as indicated by Ki-67 index. A total of 21 patients with newly diagnosed advanced gastric cancer were examined with FLT PET and FDG PET. Tumour lesions were identified as areas of focally increased uptake, exceeding that of surrounding normal tissue. For semiquantitative analysis, the maximal standardized uptake value (SUV) was calculated. For detection of advanced gastric cancer, the sensitivities of FLT PET and FDG PET were 95.2% and 95.0%, respectively. The mean (±SD) SUV for FLT (7.0 ± 3.3) was significantly lower than that for FDG (9.4 ± 6.3 p < 0.05). The mean FLT SUV and FDG SUV in nonintestinal tumours were higher than in intestinal tumours, although the difference was not statistically significant. The mean (±SD) FLT SUV in poorly differentiated tumours (8.5 ± 3.5) was significantly higher than that in well and moderately differentiated tumours (5.3 ± 2.1; p < 0.04). The mean FDG SUV in poorly differentiated tumours was higher than in well and moderately differentiated tumours, although the difference was not statistically significant. There was no significant correlation between Ki-67 index and either FLT SUV or FDG SUV. FLT PET showed as high a sensitivity as FDG PET for the detection of gastric cancer, although uptake of FLT in gastric cancer was significantly lower than that of FDG.Keywords
This publication has 35 references indexed in Scilit:
- Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective StudyClinical Cancer Research, 2008
- Imaging Gastric Cancer with PET and the Radiotracers 18F-FLT and 18F-FDG: A Comparative AnalysisJournal of Nuclear Medicine, 2007
- Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomographyCancer, 2005
- Whole-body FDG-PET imaging in the management of patients with cancerSeminars in Nuclear Medicine, 2002
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- Accuracy of FDG-PET in Gastric Cancer Preliminary ExperienceClinical Positron Imaging, 1998
- Human thymidine kinase 1. Regulation in normal and malignant cellsAdvances in Enzyme Regulation, 1995
- Activities of thymidylate synthetase and thymidine kinase in gastric cancerSurgical Oncology, 1992
- Routine production of 2-deoxy-2-[18F]fluoro-d-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resinNuclear Medicine and Biology, 1990